Low or absent GRO-α expression in both the cytoplasm of cancer cells and stroma (61/160 patients) was associated with T classification (P = 0.003), distant metastasis (P = 0.005), and TNM stage (P = 0.002; Table 2). This evidence concerns the gene CXCL1 and cancer.